Articles tagged with Stem Cell Research
Researchers have generated induced pluripotent stem cells from bats, gaining insights into the relationship between bats and viruses. The study may also shed light on bats' remarkable defenses against aging and cancer.
A 53-year-old man has been cured of HIV after receiving a stem cell transplant, marking the third person to achieve this. The patient's genome contained a mutation in the CCR5 gene, making it impossible for most HIV viruses to enter his CD4+ T-lymphocytes.
Researchers have successfully converted pluripotent stem cells into hematopoietic stem and progenitor cells using optimized transcription factors. The resulting PSC-derived cells generated all types of white blood cells in mice without giving rise to tumors or leukemias, suggesting a promising future for PSC-based transplant therapies.
Researchers have generated large-scale muscle-controlling nerve cells from ALS patients, revealing striking differences in gene expression between males and females. The study, published in Neuron, used over 450 lines of stem cells to create motor neurons that can potentially lead to the development of new therapeutics.
Researchers at USC Keck School of Medicine have identified two new avenues for treating diverse forms of ALS by suppressing genes and inhibiting proteins. The findings suggest that targeting SYF2 gene suppression and PIKFYVE kinase inhibition may lead to broadly effective treatments for the disease.
Scientists made a groundbreaking discovery that lymphatic vessels can produce both red and white blood cells, challenging the long-held belief that blood cells come solely from bone marrow. The study suggests that lymphatic vessels may play a role in fighting infection and could be important for treating certain blood cancers.
Researchers successfully transplanted human brain organoids into adult rat brains and observed functional integration, including response to visual stimulation. The study demonstrates potential for neural tissues to rebuild injured brain areas.
Researchers generated cochlear avatars from stem cells, recreating hair cell function and transmitting electrical signals. This breakthrough enables the investigation of sensorineural hearing loss mechanisms and potential treatments.
The ISSCR 2023 Annual Meeting will showcase the year's most compelling stem cell research and clinical breakthroughs. Attendees can participate in dedicated poster sessions and interact with presenters.
Leif Ludwig's analytical method allows for easier disentanglement of blood cell trajectories, enabling identification of leukemia cell development or degenerative changes. This breakthrough opens up possibility for human medicine to conduct studies in clinical practice and derive therapeutic interventions.
Researchers at Children's Hospital of Philadelphia have developed a custom-built application to automate the determination of engraftment after hematopoietic stem cell transplant. The tool has been shown to improve accuracy of reported engraftments, reducing errors in neutrophil and platelet engraftment reporting.
Researchers found a link between astrocytes from schizophrenic patients and reduced vascularization in the brain, which may contribute to the disease's metabolic flux. The study suggests that astrocytes could be a target for novel therapies to address schizophrenia.
A team of researchers from Korea and USA identified the importance of lipid homeostasis in overcoming brain cancer radioresistance. They found that regulating diacylglycerol kinase B and diacylglycerol acyltransferase 1 could potentially sensitize brain cancer cells to radiotherapy, offering a new treatment strategy.
Researchers identified 17 clusters of single cells in peripheral blood, showing upregulation of antigen processing and presentation pathways and downregulation of genes involved in ribosome pathways with age. The study also found senescent T cells resistant to apoptosis, potentially targeted for treatment.
Researchers have discovered a biological pathway that governs the life and death of stem cells, which may lead to new treatments for cancer and regenerative therapies. By manipulating cell signaling, scientists can normalize the creation of new cells, preventing excessive growth and ensuring proper tissue regeneration.
Researchers have discovered that more than 2,500 genes exhibit significant sex differences in expression in mouse alveolar type II cells, potentially explaining sex biases in lung diseases. These findings suggest that AT2 cells may play a crucial role in sex-biased differences in lung injury and repair.
Ceramides accumulate in aged muscle, impairing its function and affecting functional capacity in older adults. This finding encourages researchers to develop potential pharmaceutical agents to combat sarcopenia and age-related diseases.
Engineers create OCTOPUS device to grow organs-in-a-dish, achieving higher levels of maturity than traditional methods. The device allows for more mature organs with complex cell relationships, providing valuable tools for studying human organ development.
Researchers have successfully grown retinal cells from stem cells that can connect with neighboring cells and transmit sensory information like healthy ones. The breakthrough could lead to human clinical trials to treat degenerative eye disorders such as retinitis pigmentosa and age-related macular degeneration.
A new stem cell model allows researchers to study the earliest stages of sex determination in mice and humans, providing insights into Disorders of Sex Development (DSD). The model enables the creation of a 'mini testis' in a dish, which could lead to better understanding of DSD, infertility, and fertility restoration.
Embryonic cells use mechanical cues, known as the cell's sense of touch, to make collective decisions during tissue formation. The study reveals that cells perceive the stiffness and confinement of a 'living foam' structure, which changes its properties at the moment of differentiation.
The São Paulo School of Advanced Science on Stem Cell Biology will highlight the latest scientific advances in stem cell therapy and tissue bioengineering. Internationally renowned scientists will present state-of-the-art science and results of new research.
Researchers found no evidence of a critical mass needed to start and maintain new research fields. Instead, pioneering regions with early investment can establish dominance. However, late-comers face significant costs to catch up, as seen in China's semiconductor science, where strategic interventions over decades led to a dominant role.
Researchers discovered that MODY3 patients experience hypersecretion of insulin from β cells due to more efficient membrane depolarization. This phenomenon precedes pancreatic β cell failure and can be targeted for prevention or delay with treatments, such as diets or drugs.
Scientists have created eye tissue using patient stem cells and 3D bioprinting, providing a model for studying the genesis of age-related macular degeneration. The printed tissue exhibited patterns of early AMD, including drusen deposits and progression to late dry stage AMD.
Researchers from Harvard University developed an efficient method to make large numbers of C4-secreting human astrocytes from stem cells. A small group of about 20 drugs were identified that reduced C4 secretion, effective in both healthy and Schizophrenia patients' astrocytes.
A new gene therapy treatment has shown promising results in a clinical trial for Artemis-SCID patients, improving their immune function and reducing treatment complications. The treatment involves adding a healthy copy of the Artemis gene to the patient's own cells, resulting in improved T-cell and B-cell immunity.
Researchers have identified a Vegf-Notch signaling system that enables Muller glial cells to regenerate retinal neurons in zebrafish. This discovery may help understand why the human retina does not regenerate and could inform treatments for blindness.
A study published in Aging-US reveals changes in gene expression associated with age-related muscle loss and frailty. Researchers identified unique cellular subpopulations in aged and sarcopenic skeletal muscle, which may facilitate the development of new treatments for age-related frailty.
Researchers at UNSW Sydney have successfully induced a gastrulation-like event in human pluripotent stem cells, mimicking the early stages of embryonic development. This breakthrough could lead to new approaches for studying human development and creating personalized body tissue or organs using hydrogel materials.
The Cleveland Clinic is developing a stem cell treatment for complex regional pain syndrome, a debilitating disease that causes chronic pain, using human mesenchymal stem cells (hMSC). The research has long-term potential for providing patients an alternative to addictive opioid treatments.
Researchers discovered the underlying cause of deafness caused by swelling in the inner ear chambers. The study identified two master genes, SOX9 and SOX10, controlling hearing function and providing a new resource for diagnosis and treatment of deafness and balance problems.
A new report by The Hastings Center recommends clearer ethics guidelines and enhanced oversight for human-animal chimera research, which raises questions about animal welfare and moral status. The report also highlights the potential benefits of this research, including better disease models and organ transplantation.
Researchers at the Max Delbrück Center have successfully generated primordial germ cells from stem cells, a world's first for a large mammalian species. This milestone aims to save the northern white rhino subspecies from extinction through lab-grown egg and sperm cells.
Researchers found that activating the non-mutated form of P53 can change the fundamental makeup of cancer stem cells in mouse models of mucoepidermoid carcinoma. This new therapy approach shows promise for treating this lethal form of salivary gland cancer.
A study suggests that visceral fat cells, rather than subcutaneous fat cells, are more susceptible to infection by the COVID-19 virus. This increased susceptibility leads to a higher viral load and production of pro-inflammatory cytokines, which can exacerbate severe disease.
A study published in Nature reveals that cancer stem cells' miscommunication with their environment can trigger a self-perpetuating series of events leading to malignancy. Leptin signaling plays a surprising role in this process, which could be blocked to prevent tumor progression.
A new bioreactor system developed by KAUST scientists delivers gases to maintain physiological environments, reducing unpredictable shifts in cell growth. The system allows for more accurate and reproducible experiments in biomedical research.
Scientists at Texas A&M University found that transplanting intestinal epithelial stem cells can repair the gut and reduce inflammation, potentially preserving cognitive function after a stroke. The study suggests that targeting gut health may be key to developing more effective stroke therapies.
Researchers have developed mini eyes, or organoids, from stem cells donated by patients with Usher syndrome. These mini eyes allow scientists to study light-sensing cells and understand the development of blindness in the disease.
Albert Almada's laboratory will explore the role of Nicotinamide Adenine Dinucleotide (NAD+) in muscle repair and regeneration. Lower levels of NAD+ may be inactivating stem cell repair, and re-activating it could promote better muscle healing in older animals.
Researchers found that MK256 induced differentiation and maturation in leukemia stem cells, inhibiting proliferation of AML cell lines. The study also showed dose-dependent inhibition of the STAT pathway in both in vitro and in vivo studies.
Researchers from the University of Zurich have discovered why a stem cell transplant is effective in treating multiple sclerosis. The study found that memory T cells reappear immediately after the transplant and do not trigger an autoimmune reaction due to pre-damage caused by chemotherapy. This knowledge enables the body to gradually ...
A team of Berlin scientists has successfully grown stem cells and mini-brains from Sumatran rhino skin cells, paving the way for potential use in assisted reproduction. The next step is to create sperm cells that may help save the critically endangered species from extinction.
Researchers at the University of Helsinki have identified a promising drug candidate, TYK2 inhibitor, for preventing type 1 diabetes. The study found that inhibiting TYK2 expression reduces the destruction of pancreatic beta cells, but may also reduce beta cell production in earlier stages.
Researchers used monoclonal antibodies to suppress the immune system in mice, tracking human neural stem cell survival using luciferase. The study reveals that monoclonal antibody-mediated immunosuppression enabled long-term survival of transplanted human neural stem cells in mouse brains for at least six to eight months.
A team of scientists has made a breakthrough in growing stem cells and mini-brains from Sumatran rhino skin cells, which may help save the endangered species from extinction. The goal is to create sperm cells that can be used in artificial insemination, increasing the chances of successful breeding.
Researchers discovered stem cells in mouse dorsal root ganglia (DRG) with the potential to regenerate lost sensory neurons and glia. These cells, known as satellite glia, can become activated and generate new glia and, to a lesser extent, neurons after injury.
Researchers generated induced pluripotent stem cells and cerebral organoids from the last male Malaysian Sumatran rhino, enabling study of brain development and potentially aiding in breeding program. The technology holds promise for fighting extinction of critically endangered species.
A high-fat diet in pregnant monkeys alters the transcriptional landscape of fetal blood stem cells, leading to a hyperinflammatory response and suppressed B-cell development. The study's findings suggest that maternal obesity may influence fetal bone marrow and immune system development.
The Alpha Stem Cell Clinic will develop preclinical studies into early and later phase clinical trials with the goal of establishing advanced regenerative medicine treatments. The clinic will also foster greater collaboration with eight similar clinics across the state and educate the public about stem cell and related therapies.
The 13th Annual Meeting on Skin Challenges 2022 will address key skin ageing and challenges such as skin microbiome, cancer, inflammation, wound healing, and more. The event will feature experts from industry and academia presenting their research on these topics.
Researchers found that intensive physical therapy and implanted neural stem cells increased tissue growth, repair, and functionality in rats with cervical lesions. The combination of treatments outperformed each individual treatment alone, suggesting a new potential combination therapy for spinal cord injuries.
Scientists discovered the first direct evidence that Stargardt-related ABCA4 gene mutations affect a layer of cells in the eye called the retinal pigment epithelium (RPE). The study suggests a therapeutic strategy for the disease, which currently lacks treatment.
Researchers have successfully isolated parathyroid stem cells and maintained them in lab as organoids for an extended period. These patient-derived parathyroid organoids (PTOs) closely mimic human parathyroid tissue, enabling the study of parathyroid diseases and drug development.
A new method developed by the University of Vienna has provided deeper insights into glycolipids located on stem cell surfaces. The approach enables comprehensive analysis of gangliosides, a class of fatty sweet molecules whose composition changes during stem cell differentiation.
A new stem cell study provides insight into how neurons from individuals with post-traumatic stress disorder (PTSD) respond to stress hormones. The research found that these cells are hypersensitive to the stress hormone hydrocortisone, which could help explain why some people develop PTSD after trauma exposure.
Ruben van Boxtel's research focuses on understanding the origins of late treatment effects in children with blood cancer, exploring the role of stem cells. His work aims to find solutions to prevent these effects and predict their likelihood.
The New York Stem Cell Foundation (NYSCF) has selected six early-career researchers to join its prestigious investigator program, which provides $1.5 million in funding over five years. The award aims to accelerate treatments and cures through cutting-edge research.
Researchers have developed brain-like organoids that can be tested experimentally to uncover cellular and molecular causes of autism. The organoids, grown in a dish from human cells, self-organize into layers of cells reminiscent of the cerebral cortex, allowing scientists to study how complex neural structures arise.